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OBJECTIVE—Brown adipose tissue (BAT) regulates energy
homeostasis and fat mass in mammals and newborns and, most
likely, in adult humans. Because BAT activity and BAT mass
decline with age in humans, the impact of BAT on adiposity may
decrease with aging. In the present study we addressed this
hypothesis and further investigated the effect of age on the sex
differences in BAT activity and BAT mass.
RESEARCH DESIGN AND METHODS—Data from 260 sub-
jects (98 with BAT and 162 study date–matched control subjects)
who underwent
18F-ﬂuorodeoxyglucose positron emission to-
mography/computed tomography (
18F-FDG PET/CT) under ther-
moneutral conditions were analyzed. BAT activity and BAT mass
were determined in the upper body.
RESULTS—BAT activity and BAT mass were higher in female
(1.59  0.10 and 32  5 g vs. 1.02  0.10 and 18  4 g, both P 
0.0006) than in male subjects. In multivariate analyses, sex (P 
0.0001), age (P  0.0001), and BMI (P  0.0018) were associated
independently with BAT activity. Interestingly, only in male
subjects was there an interaction between BMI and age in
determining BAT activity (P  0.008) and BAT mass (P  0.0002);
BMI decreased with increasing BAT activity and BAT mass in the
lowest age tertile (Spearman rank correlation coefﬁcient rs 
0.38, P  0.015 and rs  0.37, P  0.017, respectively), not in
the higher age tertiles. Furthermore, BAT activity and mass
differed between female and male subjects only in the upper two
age tertiles (all P  0.09).
CONCLUSIONS—Our data corroborate that, in general, BAT
activity and BAT mass are elevated in female subjects and in
younger people. Importantly, we provide novel evidence that the
impact of BAT activity and BAT mass on adiposity appears to
decline with aging only in male subjects. Furthermore, while BAT
activity and BAT mass only moderately decline with increasing
age in female subjects, a much stronger effect is found in male
subjects. Diabetes 59:1789–1793, 2010
B
rown adipose tissue (BAT) is involved in the
dissipation of chemical energy as heat, thereby
maintaining core temperature in small mammals
and in newborn humans, particularly during cold
exposure without shivering (1). This cold- and also diet-
induced heat production is considered as a target in the
prevention and treatment of obesity (2–4). However, be-
cause BAT mass and BAT activity in humans, i.e., in
contrast to rodents, is rapidly lost within the ﬁrst years of
life, it was thought for a long time that it has only a minor
impact on energy homeostasis after infancy. In 2007,
Nedergaard, Bengtsson, and Cannon (5) summarized and
reviewed several studies showing that BAT is present in
adult humans at a considerable amount, that human BAT
activity is acutely cold-induced, and that human BAT is
stimulated via the sympathetic nervous system. Impor-
tantly, in 2009, areas identiﬁed as possible BAT in human
scans were found to truly represent BAT, as they were
positive for the presence of BAT-unique UCP1 expres-
sion (6). In the same year, studies using the combined
18F-ﬂuorodeoxyglucose positron emission tomography/
computed tomography (
18F-FDG-PET/CT) technology
provided strong and convincing evidence for a major role
of BAT in the regulation of body weight and energy
homeostasis in adult humans (7–14). Thus, the presence of
BAT may help to explain the large interindividual differ-
ences in energy efﬁciency in regard to weight gain in
humans (15–17).
Several points have now emerged concerning the regu-
lation of BAT mass and BAT activity and their relation-
ships with age, sex, adiposity, and glucose and lipid
metabolism in humans. Among them is the question of
whether BAT mass and BAT activity constantly decline
during childhood, adolescence, and adulthood. While BAT
mass was found to strongly decline with age in some
recent studies (7,12), as well as in our study (11), a weaker
trend was found in another study (13), and no decline with
increasing age was reported in a study by van Marken et al.
(9). Furthermore, it is unclear whether such a decline in
BAT mass and BAT activity may help to explain the
observed overall increase in adiposity with aging. In
addition, it is unknown which factors are responsible for
the often observed higher BAT activity in female than in
male subjects of similar age and whether age affects this
relationship.
RESEARCH DESIGN AND METHODS
A total of 3,604 patients underwent 5,776 consecutive
18F-FDG-PET/CT
examinations between January 2005 and July 2009 at the Department of
Radiology of the University of Tu ¨bingen (Tu ¨bingen, Germany) for a variety of
diagnostic reasons. BAT was documented in the radiologist’s report for 110
scans. In a previous analysis a total of 198 scans from patients without
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diabetes.diabetesjournals.org DIABETES, VOL. 59, JULY 2010 1789documented BAT, who had a PET/CT examination on the same day, were
matched to these scans (11). For analyses with continuous parameters, only
one PET/CT scan from each patient was included in the present evaluation,
resulting in a total of 260 scans. The study was approved by the ethics
committee of the University of Tu ¨bingen.
PET/CT imaging. Most patients used a car, and few used public transporta-
tion, to get to the Tu ¨bingen University Hospital. From the time of entry in the
hospital until the PET/CT measurement, patients spent about 2 h in an
air-conditioned environment at about 22°C. Patients fasted overnight for at
least 6 h. All patients underwent PET/CT measurements on the Hi-Rez
Biograph 16 (Siemens Medical Solutions, Knoxville, TN), consisting of a
high-resolution three-dimensional LSO PET and a 16-row multidetector CT.
Image analysis. FDG distribution was evaluated visually and semiquantita-
tively using average and maximum standard uptake values (SUVmean, SUVmax).
BAT was suspected if 1) focal FDG uptake exceeded normal regional tracer
accumulation and exceeded SUVmax values of 2.0 in 2) tissue with a density
between 250 and 50 Hounsﬁeld units (HU) and fat-like appearance on CT
and 3) characteristic localization bilaterally in the neck and supra- and
infraclavicular regions and paravertebrally (lobster sign), unrelated to muscle,
joints, and pathological ﬁndings (18). For the assessment of BAT volume and
activity, we used three-dimensional (3D) isocontour regions of interest (ROIs)
with an SUV isocontour threshold of 2.0 (7,18). In patients without BAT
(matched control subjects), ellipsoid 3D ROIs were manually placed over
nuchal adipose tissue.
In the present study, mean SUVs were automatically derived from a large
3D ROI comprising the whole head and neck region as previously described
(7,8,18) (supplemental Figures A and B, available in an online appendix at
http://diabetes.diabetesjournals.org/cgi/content/full/db10-0004/DC1) and are
referred to as “single” ROI measurements (SUVsing). In addition, each mani-
festation of BAT was individually assessed, resulting in multiple 3D isocontour
ROIs (SUVmult), without overlap (supplemental Figures C and D). Outdoor
temperature of the study dates in the city of Tu ¨bingen was obtained from the
local weather station.
Statistical analyses. Differences between male and female subjects were
determined using the nonparametric Wilcoxon rank-sum test. Data that were
not normally distributed (Shapiro-Wilk W test) were logarithmically trans-
formed to approximate a normal distribution. Patients with documented BAT
activity in the radiologist’s report were matched to patients without BAT. This
resulted in skewed distributions for BAT activity and BAT mass that were
apparent even after logarithmical transformation of the data. Therefore, for
correlation analyses involving BAT mass and BAT activity, Spearman rank
correlation coefﬁcient (rs) was calculated. To adjust the effects of covariates
and identify independent relationships, we performed multiple regression
analyses.
RESULTS
Age, anthropometrics, and metabolic characteristics of the
patients covered a wide range (Table 1). First we tested
whether outdoor temperature was associated with BAT
activity. No signiﬁcant relationship was found with BAT
activity determined as SUVsing (rs  0.05, P  0.43) or
SUVmult (rs  0.04, P  0.49). Thus, no correction for
outdoor temperature was necessary for the following
analyses. Next we tested the relationships of BAT activity
determined as SUVsing,o rS U V mult with each other and
with age, sex, and BMI. The BAT activity measures were
closely correlated with each other (rs  0.73, P  0.0001).
However, SUVmult consistently correlated stronger with
age, sex, and BMI than SUVsingle (data not shown), sug-
gesting that BAT activity individually assessed with multi-
ple 3D isocontour ROIs may be superior to the single
ROI measurements. Therefore, for the further analyses,
SUVmult was used as an estimate of BAT activity.
Next we found that both BAT activity (1.59  0.10 vs.
1.02  0.10, P  0.0003) and BAT mass (32  5 vs. 18  4g ,
P  0.0006) were higher in female than in male subjects. In
univariate analyses, age and BMI correlated negatively
with BAT activity (rs  0.44, P  0.0001 and rs  0.33,
P  0.0001) and with BAT mass (rs  0.34, P  0.0001
and rs  0.21, P  0.0006). In multivariate analyses
(Table 2), sex (P  0.0001), age (P  0.0001), and BMI
(P  0.0018) remained independently associated with BAT
activity. Similar relationships, although weaker, were
found for BAT mass with sex (P  0.0002) and age (P 
0.0001), however, not for BAT mass with BMI (P  0.37).
Because age turned out to be the strongest determinant
of BAT activity and BAT mass, we studied whether the
relationships between BAT activity and BAT mass with
BMI and sex are similar among different age categories.
Interestingly, there was an interaction between age and
BMI in determining BAT activity (P  0.008) and BAT
mass (P  0.0002) in male but not in female subjects (P 
0.41 and P  0.61). When males were divided into tertiles,
BMI decreased with increasing BAT activity and BAT mass
only in the lower age tertile (Fig. 1A and B; rs  0.38, P 
0.015 and r  0.37, P  0.017) but not in the upper two
tertiles (Fig. 1C–F).
Finally, we tested whether age also impacts the ob-
served differences in BAT activity and BAT mass between
male and female subjects. Interestingly, BAT mass and
BAT activity were not different in subjects in the lowest
age tertile (Fig. 2A and B); however, BAT mass and BAT
activity were higher in female than in male subjects in the
2nd and 3rd age tertiles (Fig. 2C–F).
DISCUSSION
In the present study we addressed the questions of
whether BAT activity has similarly strong impacts on the
development of adiposity in younger and older people and
whether the observed sex differences in BAT activity and
BAT mass are apparent among several age categories.
First we determined BAT activity on
18F-FDG-PET/CT
TABLE 1
Subject characteristics
Characteristics Mean  SE Range
Sex (female/male) 136/124
Age (years) 48  1 11–82
Height (cm) 170  1 112–200
Weight (kg) 71.3  1.0 35.0–137.0
BMI (kg/m
2) 24.5  0.3 15.5–40.8
Fasting glucose (mmol/l) 5.17  0.06 2.50–10.22
BAT activity 1.32  0.07 0.16–3.84
BAT mass (g) 25.24  3.20 0.02–287.90
TABLE 2
Relationships of BAT activity and BAT mass with sex, age, and
BMI in multivariate linear regression analyses
Parameter Estimate SE P
BAT activity
Intercept 3.66 0.81 0.0001
Male sex 0.20 0.05 0.0001
Age 0.02 0.05 0.0001
BMI 0.85 0.27 0.0018
BAT mass
Intercept 5.96 2.61 0.023
Male sex 0.56 0.15 0.0002
Age 0.06 0.01 0.0001
BMI 0.77 0.86 0.37
Intercept sets the “baseline” event rate when all covariate values are
set equal to zero. Estimates are the coefﬁcients of the linear model
found by least squares. SE is the standard error, an estimate of the
standard deviation of the distribution of the parameter estimate. P 
0.05 is often considered signiﬁcant evidence that the parameter is not
zero.
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ment or using multiple 3D isocontour ROIs to assess BAT
activity at each manifestation, individually. We found that
these measurements were highly correlated with each
other. Furthermore, BAT activity estimated from the mul-
tiple ROIs turned out to be more strongly associated with
age, sex, and BMI, indicating that this method may be the
more accurate one.
Next we conﬁrmed the ﬁndings of most studies that BAT
activity is higher in female subjects. These ﬁndings indi-
cate that yet unknown parameters in humans, possibly sex
hormones, may be involved in the regulation of BAT
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FIG. 1. Relationships of BMI with BAT activity and BAT mass in male subjects divided into tertiles by age (Spearman rank correlation)
(1st/2nd/3rd age tertiles, respectively: n  83/90/87).
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UCP-1 expression (higher levels in females at 22°C) was
found in rats (19). However, in that study the steroid
hormones -estradiol, estrone, and progesterone did not
increase but actually reduced norepinephrine-induced
UCP-1 synthesis in brown adipocytes that were differenti-
ated in primary culture. In another study in rodent brown
adipocytes differentiated in culture, testosterone treat-
ment dose-dependently inhibited norepinephrine-induced
UCP-1 mRNA expression, while 17--estradiol did not
have any remarkable effect (20). In addition, because sex
hormones modulate 5-iodothyronine deiodinase activity
(21), which is responsible for enzymatic conversion of
thyroxine into the bioactive form, triiodothyronine, which
regulates the thermogenic function of BAT (22), indirect
effects of sex steroids may be involved in the regulation of
BAT activity. Because in our study a large decline in BAT
activity was observed in 43- to 56-year-old male subjects,
who have declining testosterone levels, it would be impor-
tant to speciﬁcally study the effect of testosterone levels
and/or testosterone supplementation on BAT activity.
We then found strong negative univariate correlations
of BAT activity both with age and BMI. In multivariate
analyses BAT activity was independently associated
with age, sex, and BMI. This supports that, in general,
BAT activity is lower in male subjects, declines with
aging, and most likely has direct effects on the regula-
tion of adiposity.
We next investigated whether the relationship of BAT
activity with BMI is similarly strong among different
age-groups. We can provide novel data that, only in
younger male subjects, a signiﬁcant negative relationship
between BAT activity and BMI can be found. This suggests
that in older male subjects BAT is not an important
regulator of adiposity, anymore. In contrast, in female
subjects similarly strong negative relationships of BAT
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FIG. 2. Differences between sex in BAT activity and BAT mass (Wilcoxon rank-sum test) (1st/2nd/3rd age tertiles for male (and female) subjects,
respectively: n  40 (43)/41 (49)/43 (44).
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groups. An interaction of BAT with age in determining BMI
was found in the study by Cypess et al. (7). In contrast to
our data, in that study the relationship between the
presence of BAT and BMI became stronger with increasing
age. Differences between both studies may be explained
by the fact that male and female subjects were analyzed
together in the study by Cypess et al. and there were
differences in the age of the studied populations and
differences in the methodology used for detection of BAT.
Finally we investigated whether age impacts the ob-
served differences in BAT activity between male and
female subjects. Interestingly, these differences were not
apparent in the lowest age tertile. However, while in both
male and female subjects BAT activity declined with aging,
this process appears to be accelerated in male subjects.
Thus, a signiﬁcantly higher BAT activity in female subjects
can be found, particularly in older women.
Limitations of our study are that our measurements of
BAT activity were not done under cold exposure, which
further increases BAT activity and thus may allow for
more precise determination of BAT activity and BAT mass.
Nevertheless, because such studies with a large number of
subjects are not available yet, ﬁndings from our and other
studies may help to stimulate and focus such research in
this important ﬁeld in the future.
In conclusion, we provide novel data that only in male
subjects the impact of BAT activity on adiposity appears to
decline with aging. In addition, while with increasing age
BAT activity only moderately declines in female subjects,
a much stronger effect is found in male subjects. If
conﬁrmed by other studies, these ﬁndings may consider-
ably impact future research about the role of BAT in
humans.
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